ChartMill · Aug 19, 2026
What's going on in today's after hours session
After the closing bell on Wednesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.
VR
NASDAQ · VRAX
Virax Biolabs Group Limited
Healthcare · Biotechnology
$2.44
Down-$0.05 (-1.84%)
Updated Sep 26, 2026, 1:39 AM
SID Score
5.4/10
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 1.92M
- P/E ratio
- -0.37
- Dividend yield
- 0.00%
- 52-week range
- $0.10 – $13.19
- Volume
- 20.65K
- Avg. volume
- 5.08M
Price performance
VRAX price history
1M range · 0 trading sessions · Daily adjusted prices
VRAX does not have enough price history for the selected period.
Data unavailable
Market data is busy. Please try again shortly.
Latest VRAX news
The latest Smart Investors Daily articles mentioning VRAX.
Stock researchCompany · Overview
VRAX research
Overview
Company profile and research snapshot.
Company profile
Virax Biolabs Group Ltd is a biotechnology company focused on the prevention, detection, diagnosis and risk management of viral diseases that also engages in distribution of diagnostics test kits of various viral threats. It is developing a proprietary T-Cell Test technology with the intention of providing an immunology profiling platform that assesses each individual's immune risk profile against world-wide viral threats. T-Cell testing is particularly effective in the diagnosis and therapeutics of COVID-19 as well as other threats including Hepatitis B, Malaria, Herpes (HSV-1) and Human Papillomavirus (HPV).
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jan 9, 2026 | HC Wainwright & Co. | Buy | — |
| Mar 31, 2025 | HC Wainwright & Co. | Buy | — |
News briefing
No generated briefing is available yet.
Benzinga · Aug 19, 2026
12 Health Care Stocks Moving In Wednesday's After-Market Session
Gainers BioVie (NASDAQ:BIVI) stock increased by 15.7% to $1.55 during Wednesday's after-market session. The market value of their outstanding shares is at $7.2 million. The company's, Q4 earnings came out 4
Benzinga · Aug 19, 2026
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Gainers Tenon Medical (NASDAQ:TNON) stock rose 122.5% to $12.13 during Wednesday's pre-market session. The market value of their outstanding shares is at $3.6 million. As per the news, the Q2 earnings report came
Benzinga · Jul 24, 2026
Virax Biolabs Files Prospectus For Offering 1.682M Ordinary Shares
https://www.sec.gov/Archives/edgar/data/1885827/000119312526316130/vrax-20260724.htm
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
